Improving immune responses in breast cancer treatment
Enhanced antigen-lymphocyte interactions to improve immune checkpoint blockade in breast cancer
This study is looking at how improving the way immune cells interact with cancer can help breast cancer patients respond better to a specific treatment called immune checkpoint blockade therapy.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10880679 on NIH RePORTER |
What this research studies
This research investigates how enhancing interactions between immune cells and antigens can improve the effectiveness of immune checkpoint blockade therapy in breast cancer. The study focuses on understanding the role of tumor-draining lymph nodes in activating anti-cancer T cells, which are crucial for a successful immune response. Using animal models, researchers will explore how changes in lymph fluid dynamics and local environments affect these interactions and the overall immune response to cancer. The goal is to identify ways to boost the response rates of breast cancer patients to this promising treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer patients who have not responded well to current immune checkpoint blockade therapies.
Not a fit: Patients with early-stage breast cancer or those who are not receiving immune checkpoint blockade therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes for breast cancer patients by increasing the effectiveness of immune checkpoint blockade therapies.
How similar studies have performed: Previous research has shown promising results in enhancing immune responses through similar approaches, indicating potential for success in this area.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: O'melia, Meghan — Massachusetts General Hospital
- Study coordinator: O'melia, Meghan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.